Actively Recruiting

Phase Not Applicable
Age: 18Years - 59Years
All Genders
NCT06814275

Project neuroARTEMIS

Led by Wake Forest University Health Sciences · Updated on 2025-09-11

189

Participants Needed

1

Research Sites

191 weeks

Total Duration

On this page

Sponsors

W

Wake Forest University Health Sciences

Lead Sponsor

F

Florida International University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research is to understand how chronic stress affects the way our brain and immune systems function, and in turn how this affects the way people feel, think, and behave. By learning more about how these processes work, the hope is to be able to develop better treatments to help with problems like depression and substance use. This study is intended for individuals that are HIV positive, currently taking prescription antiretroviral medications, and use stimulants. Through this intervention, the aim is to determine if this positive affect intervention can lead to reductions in stimulant use and depressed mood.

CONDITIONS

Official Title

Project neuroARTEMIS

Who Can Participate

Age: 18Years - 59Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 59 years
  • Weekly stimulant use reported in the past month or a score of 4 or higher on substance use screening
  • Confirmed diagnosis of HIV
  • Currently taking daily oral antiretroviral therapy (ART) medication
  • Fluent and literate in English
Not Eligible

You will not qualify if you...

  • Acute brain infections such as neurosyphilis or toxoplasmosis
  • Acutely symptomatic bipolar I disorder or psychotic disorder
  • Currently prescribed immunomodulatory medications or other immunotherapy
  • Any contraindications for MRI scanning
  • On antidepressant medication regimen for at least 2 months if applicable

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Wake Forest University School of Medicine

Winston-Salem, North Carolina, United States, 27101

Actively Recruiting

Loading map...

Research Team

C

Christina S Meade, PhD

CONTACT

S

Sheri L Towe, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here